appScorecard
Performance
LowHasn't faired well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
News & Opinions
Biofil Chemicals & Pharmaceuticals Ltd leads gainers in ‘B’ group
4 months ago•Business Standard
NGL Fine Chem consolidated net profit declines 66.43% in the September 2022 quarter
5 months ago•Business Standard
NGL Fine Chem standalone net profit declines 65.05% in the September 2022 quarter
5 months ago•Business Standard
NGL Fine Chem standalone net profit declines 45.07% in the March 2022 quarter
10 months ago•Business Standard
NGL Fine Chem consolidated net profit declines 50.36% in the March 2022 quarter
10 months ago•Business Standard
NGL Fine Chem Consolidated December 2021 Net Sales at Rs 81.37 crore, up 11.89% Y-o-Y
1 year ago•Moneycontrol
NGL Fine Chem sheds 15% after profit slumps in Q3
1 year ago•Economic Times